News

Filter

Brazil's atrial fibrillation market expected to grow at 31% pa over next five years

22-01-2013

The Brazilian market for atrial fibrillation will increase at a rate of 31% per year from 2011 to 2016,…

BayerBoehringer IngelheimBristol-Myers SquibbCardio-vascularDaiichi SankyoEliquisLixianaMarkets & MarketingPharmaceuticalPradaxaSouth AmericaXarelto

Brazil's atrial fibrillation market to grow at 31% annually over the next five years

19-12-2012

The Brazilian market for atrial fibrillation will increase at a rate of 31% per year from 2011 to 2016,…

BayerBoehringer IngelheimBristol-Myers SquibbCardio-vascularDaiichi SankyoEliquisLixianaMarkets & MarketingPfizerPharmaceuticalPradaxaPricingSouth AmericaXarelto

Brazil declines patent extensions for Aprovel and Geodon

02-03-2011

A Regional Court in Rio de Janeiro declined to extend the validity of two patents relating to Sanofi-Aventis…

AprovelBristol-Myers SquibbCardio-vascularGeodonNeurologicalPatentsPfizerPharmaceuticalSanofi-AventisSouth America

Back to top